Aljadhey’s career spans academia, research, and high-level executive leadership. Since 2016, he has served as the Chief Executive Officer of the Saudi Food and Drug Authority (SFDA) and Vice Chairman of its Board, driving institutional reforms, safeguarding public health, and strengthening pharmaceutical governance. His contributions bridge scientific expertise with executive leadership to elevate healthcare standards nationally and globally.
Chairman of the Board of Trustees
Hisham Aljadhey
Dr. Hisham Aljadhey has been appointed as the Chairman of the Board of Trustees at Prince Mohammed bin Salman College of Business and Entrepreneurship. With an extensive career in pharmaceutical sciences, regulatory affairs, and public health leadership, he has become one of the foremost figures shaping healthcare policies and advancing medical safety frameworks in Saudi Arabia.

Career Journey
– Chairman of the Board of Trustees – Prince Mohammed bin Salman College of Business and Entrepreneurship (Current) – Chief Executive Officer & Vice Chairman of the Board – Saudi Food and Drug Authority (2016 – Present) – Dean, College of Pharmacy – King Saud University – Supervisor of Pharmacy Services – King Saud University Medical City – Vice Dean for Graduate Studies & Research – College of Pharmacy, KSU – Director – Drug Safety Research Chair, KSU – Assistant Research Roles – University of North Carolina, University of Aberdeen, and Universiti Sains Malaysia
Strategic Contributions
– Pioneered pharmaceutical epidemiology and drug safety research across Saudi Arabia and the Gulf region. – Directed the establishment of advanced frameworks in bio-pharmacovigilance and patient safety. – Published over 100 peer-reviewed scientific papers and delivered 80+ conference lectures worldwide. – Supervised more than 25 graduate students, contributing to the academic and scientific ecosystem. – Served as Founding President of the Gulf Chapter of the International Society for Pharmacoepidemiology.
Committees & National Roles
– Vice Chairman – NUPCO (National Unified Procurement Company for Medical Supplies) – Board Member – Saudi Public Health Authority – Board Member – Saudi Patient Safety Center – Board Member – Saudi Health Council – Board Member – National Institute for Health Research & Safety – International Expert – WHO Primary Care Patient Safety Research Group
Academic Background & Professional Certifications
– PhD in Pharmaceutical Epidemiology & Drug Safety – University of North Carolina at Chapel Hill, USA – Master’s Degree – Purdue University, USA – Doctor of Pharmacy (Pharm.D.) – King Saud University, KSA – Accredited ASHP Residency – Winchester Medical Center, Virginia, USA – Editorial Board Member & Reviewer – International peer-reviewed journals in pharmacoepidemiology and drug safety – Graduate – Leadership Development and specialized programs in clinical and public health research
Leadership Impact
Dr. Hisham Aljadhey’s leadership has been pivotal in advancing pharmaceutical regulation, promoting drug safety, and embedding patient safety at the heart of national healthcare strategies. Through his roles at SFDA and across academic, research, and advisory bodies, he continues to shape Saudi Arabia’s health ecosystem in alignment with Vision 2030, positioning the Kingdom as a global reference in regulatory excellence and public health innovation.
Share on